Founded 1990 · HQ: USA
Accuray's CyberKnife and Radixact robotic radiation therapy systems treat cancer with sub-millimetre precision, installed in over 1,100 centres in 80 countries.
Accuray holds the #5 position in the category with an automation score of 1.9, determined by a composite of R&D investment, AI patent filings, and operational fleet metrics.
With an annual R&D commitment of $0.12 billion and 210 filed patents, Accuray is an established player in the global landscape. The company is headquartered in USA, one of the world's leading automation economies.
🔍 Data Provenance
Last verified: Q1 2026 (February)
Sources: Accuray 10-K 2025; USPTO; ASTRO industry census
Figures are research-backed estimates verified quarterly. R&D spend accurate to ±10%; patent counts vary by registry. Full methodology →
Want the full dataset on Accuray?
Upgrade to Pro for CSV access
→